| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Cell Biology Unit, Christian de Duve Institute of Cellular Pathology (C.G., P.L., I.K., P.H., C.P., V.R., Y.E., P.J.C., E.M.), and Department of Pathology, Saint Luc University Clinics (C.G., E.M.), Medical School of the Université Catholique de Louvain, B-1200 Brussels, Belgium; and Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire Saint Pierre, Medical School of the Université Libre de Bruxelles (M.V., P.T.), B-1000 Brussels, Belgium
Address all correspondence and requests for reprints to: Dr. Pierre J. Courtoy, Cell Biology Unit, UCL-7541, avenue Hippocrate 75, B-1200 Brussels, Belgium. E-mail: courtoy{at}cell.ucl.ac.be
The pathogenesis of irregular endometrial bleeding, the main reason for
stopping contraception with progestins only, is unknown. Based on the
recent reappraisal of the mechanisms of menstrual bleeding, we
hypothesized that matrix metalloproteinases initiate this disorder.
Volunteers upon Norplant treatment provided endometrial biopsies at the
start of a bleeding episode and during nonbleeding intervals. Focal
stromal breakdown, collagen fiber lysis, and collagenase-1
messenger ribonucleic acid were evidenced in most bleeding
endometria, but never in the nonbleeding ones. In the breaking down
areas, immunolabeling for gelatinase A was strongly increased, and that
of progesterone and estrogen receptors was decreased. Explants from
bleeding endometria produced high collagenase and gelatinase
activities, whereas release from nonbleeding endometria was negligible.
Bleeding endometria released more latent and active forms of
collagenase-1 and active gelatinases A and B, but less tissue inhibitor
of metalloproteinases-1, than nonbleeding endometria. Collagenase-1
release closely correlated with that of interleukin-1
. In contrast,
N-acetyl-ß-hexosaminidase and tissue inhibitor of
metalloproteinases-2 were similarly released in both groups. Thus,
endometrial bleeding occurs together with focal stromal breakdown,
collagen lysis, expression and activation of several matrix
metalloproteinases, and decreased production of tissue inhibitor of
metalloproteinases-1. These results may lead to new pharmacological
treatment of this common medical problem.
This article has been cited by other articles:
![]() |
C. M. Pretto, H. P. Gaide Chevronnay, P. B. Cornet, C. Galant, D. Delvaux, P. J. Courtoy, E. Marbaix, and P. Henriet Production of Interleukin-1{alpha} by Human Endometrial Stromal Cells Is Triggered during Menses and Dysfunctional Bleeding and Is Induced in Culture by Epithelial Interleukin-1{alpha} Released upon Ovarian Steroids Withdrawal J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4126 - 4134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Labied, C. Galant, M. Nisolle, S. Ravet, C. Munaut, E. Marbaix, J.-M. Foidart, and F. Frankenne Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., September 23, 2008; (2008) den339v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stephanie, S. Labied, S. Blacher, F. Frankenne, C. Munaut, V. Fridman, A. Beliard, J.-M. Foidart, and M. Nisolle Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., December 1, 2007; 22(12): 3084 - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B Morison, J. Zhang, T. J Kaitu'u-Lino, I. S Fraser, and L. A Salamonsen The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women Reproduction, January 1, 2007; 133(1): 309 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickey, J. Crewe, L. A. Mahoney, D. A. Doherty, I. S. Fraser, and L. A. Salamonsen Mechanisms of Irregular Bleeding with Hormone Therapy: The Role of Matrix Metalloproteinases and Their Tissue Inhibitors J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3189 - 3198. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vassilev, C. M. Pretto, P. B. Cornet, D. Delvaux, Y. Eeckhout, P. J. Courtoy, E. Marbaix, and P. Henriet Response of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Messenger Ribonucleic Acids to Ovarian Steroids in Human Endometrial Explants Mimics Their Gene- and Phase-Specific Differential Control in Vivo J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5848 - 5857. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Cornet, C. Galant, Y. Eeckhout, P. J. Courtoy, E. Marbaix, and P. Henriet Regulation of Matrix Metalloproteinase-9/Gelatinase B Expression and Activation by Ovarian Steroids and LEFTY-A/Endometrial Bleeding-Associated Factor in the Human Endometrium J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1001 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Galant, M. Berliere, D. Dubois, J.-C. Verougstraete, A. Charles, P. Lemoine, I. Kokorine, Y. Eeckhout, P. J. Courtoy, and E. Marbaix Focal Expression and Final Activity of Matrix Metalloproteinases May Explain Irregular Dysfunctional Endometrial Bleeding Am. J. Pathol., July 1, 2004; 165(1): 83 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Noguchi, T. Sato, M. Hirata, T. Hara, K. Ohama, and A. Ito Identification and Characterization of Extracellular Matrix Metalloproteinase Inducer in Human Endometrium during the Menstrual Cycle in Vivo and in Vitro J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6063 - 6072. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Cornet, C. Picquet, P. Lemoine, K. G. Osteen, K. L. Bruner-Tran, S. Tabibzadeh, P. J. Courtoy, Y. Eeckhout, E. Marbaix, and P. Henriet Regulation and Function of LEFTY-A/EBAF in the Human Endometrium. mRNA EXPRESSION DURING THE MENSTRUAL CYCLE, CONTROL BY PROGESTERONE, AND EFFECT ON MATRIX METALLOPROTEINASES J. Biol. Chem., November 1, 2002; 277(45): 42496 - 42504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Vincent, J. Zhang, A. Ostor, P.A.W. Rogers, B. Affandi, G. Kovacs, and L.A. Salamonsen Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum. Reprod., May 1, 2002; 17(5): 1189 - 1198. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |